Income Tax Bill: from complexity to clarity
With its focus on clarity and simplicity, the new Bill will lead to a more accessible and responsible tax system ...
Biogen Still Has Competitive Advantages in Neurology, but Its Moat Looks Narrow
We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
BlackRock CEO Larry Fink has an important message for the next wave of American retirees — here's how he says you can best weather the US retirement crisis
As sage billionaires go, BlackRock chairman and CEO Larry Fink belongs in the same rarefied air as Warren Buffett. And while ...
Hosted on MSN5h
Your letters: Lesson in negotiations for city
Re: Collaboration on development helps build great cities, opinion, Feb. 8 Some outstanding Calgary business leaders taught any of us who would listen that, “In negotiations, always leave something on ...
SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial
In a report released today, Joon Lee from Truist Financial maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report). The ...
GlobalData on MSN10h
Royalty Pharma pays $250m for rights to Biogen’s lupus drug
Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...